New approaches for imaging tumour responses to treatment.

Nature Reviews. Cancer
Kevin M Brindle

Abstract

Tumour responses to treatment are still largely assessed from imaging measurements of reductions in tumour size. However, this can take several weeks to become manifest and in some cases may not occur at all, despite a positive response to treatment. There has been considerable interest, therefore, in non-invasive techniques for imaging tissue function that can give early evidence of response. These can be used in clinical trials of new drugs to give an early indication of drug efficacy, and subsequently in the clinic to select the most effective therapy at an early stage of treatment.

References

Jan 1, 1991·Trends in Biochemical Sciences·F M JeffreyA D Sherry
Nov 1, 1993·International Journal of Radiation Biology·R E MeynL J Peters
Mar 24, 1998·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·B DubrayJ M Cosset
Nov 11, 1998·Nature Medicine·A F ShieldsT J Mangner
Mar 27, 1999·Neuroreport·A L GiraudL Collet
Apr 20, 1999·Nature Biotechnology·R WeisslederA Bogdanov
Jul 3, 1999·The Journal of Biological Chemistry·M L AnthonyK M Brindle
Oct 16, 1999·Proceedings of the National Academy of Sciences of the United States of America·T J SweeneyC H Contag
Dec 2, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J NuutinenH Minn
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·J W BulteJ A Frank
Mar 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·V NtziachristosB Chance
Apr 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M SchellingM Schwaiger
Jun 28, 2000·Physics in Medicine and Biology·R SinkusD Holz
Aug 5, 2000·International Journal of Radiation Oncology, Biology, Physics·J NuutinenH Minn
Aug 10, 2000·Neoplasia : an International Journal for Oncology Research·J KurhanewiczS J Nelson
Sep 23, 2000·Nature·P Carmeliet, R K Jain
Apr 3, 2001·Nature Biotechnology·A BeckerC Grötzinger
Apr 27, 2001·Radiology·R Weissleder, U Mahmood
Jun 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W A WeberU Fink
Aug 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·M DoubrovinJ Gelovani Tjuvajev
Oct 24, 2001·European Journal of Radiology·M SalernoE E de Lange
Dec 26, 2001·Experimental Hematology·J HardyC H Contag
Dec 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·S Bhaumik, S S Gambhir
Feb 28, 2002·Radiology·G Allan JohnsonLaurence W Hedlund
May 23, 2002·Current Opinion in Chemical Biology·Martin TrepelRenata Pasqualini
May 25, 2002·European Journal of Nuclear Medicine and Molecular Imaging·Hinrich WiederWolfgang Andreas Weber
Sep 5, 2002·Nature Reviews. Cancer·Sanjiv Sam Gambhir
Sep 28, 2002·Journal of Magnetic Resonance Imaging : JMRI·Silvio AimeFabio Maggioni
Dec 20, 2002·Cancer·Katherine A McGlynnRobert E Tarone
Mar 12, 2003·Genes & Development·Tarik F Massoud, Sanjiv S Gambhir
May 27, 2003·Cancer·Brad Zebrack
Jun 5, 2003·Nature Medicine·Donald M McDonald, Peter L Choyke

❮ Previous
Next ❯

Citations

Sep 10, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Kung-Chu HoTzu-Chen Yen
Apr 19, 2011·Apoptosis : an International Journal on Programmed Cell Death·Bryan A SmithBradley D Smith
Apr 25, 2013·Apoptosis : an International Journal on Programmed Cell Death·Hongliang WangKening Wu
Nov 26, 2009·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Denis RommelThierry Duprez
Nov 1, 2011·Endocrine·Tim I M Korevaar, Ashley B Grossman
May 26, 2012·Analytical Chemistry·Lisa M ManusThomas J Meade
Jun 9, 2011·Accounts of Chemical Research·Joseph Della RoccaWenbin Lin
May 11, 2012·The Journal of Physical Chemistry. a·Lloyd LumataZoltan Kovacs
Apr 4, 2008·Nature·Ralph Weissleder, Mikael J Pittet
Jul 26, 2008·Nature Nanotechnology·Wendy R SanhaiMauro Ferrari
Jan 19, 2008·Nature Reviews. Cancer·Kevin Brindle
Sep 1, 2011·Nature Reviews. Drug Discovery·Matthew G Vander Heiden
Feb 2, 2012·Chemical Communications : Chem Comm·Hailong LiErkang Wang
Nov 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ferdia A GallagherKevin M Brindle
Nov 28, 2013·Proceedings of the National Academy of Sciences of the United States of America·Christine FeigDouglas T Fearon
Nov 26, 2008·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Fiona Kyle, James Spicer
Mar 1, 2010·Therapeutic Advances in Medical Oncology·Sunali MehtaCristin Print
Dec 3, 2008·Disease Models & Mechanisms·Massimiliano di PietroRebecca C Fitzgerald
Dec 17, 2009·Future Oncology·Michael C Kolios, Gregory J Czarnota
Mar 23, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Feng WangKazutoshi Suzuki
Dec 10, 2013·Nature Medicine·Tiago B RodriguesKevin M Brindle
Feb 22, 2014·Der Radiologe·K PinkerP Baltzer
Aug 10, 2013·Medical Physics·Ali Sadeghi-NainiGregory J Czarnota
Jul 23, 2013·Advances in Colloid and Interface Science·Mohammed S Khan Siddaramaiah H
Aug 7, 2012·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Stefan WiehrBernd J Pichler
May 3, 2011·Journal of Biomedical Optics·Myunghwan ChoiChulhee Choi
Apr 13, 2010·Journal of Cancer Research and Clinical Oncology·Thomas ZiebartWolfgang Mueller-Klieser
Sep 3, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Nathalie SchleichVéronique Préat
Mar 10, 2016·Progress in Nuclear Magnetic Resonance Spectroscopy·Teresa W-M Fan, Andrew N Lane
Feb 18, 2015·Current Opinion in Biotechnology·Pengcheng ZhangHonggang Cui
Jun 14, 2013·Translational Oncology·Ali Sadeghi-NainiGregory J Czarnota
Mar 19, 2013·Journal of Healthcare Engineering·Weiren ChengYe Liu
Dec 15, 2012·Journal of Colloid and Interface Science·Xavier MuletCalum J Drummond

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.